These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis. Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY. Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992 [Abstract] [Full Text] [Related]
10. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease. Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA. Kidney Blood Press Res; 2009 Jul; 32(5):373-9. PubMed ID: 19887825 [Abstract] [Full Text] [Related]
12. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A. Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [Abstract] [Full Text] [Related]
14. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea. Fabbian F, De Giorgi A, Portaluppi F, Zuliani G. Gerontology; 2012 May; 58(1):50-5. PubMed ID: 21540563 [Abstract] [Full Text] [Related]